Immunotherapy methods emerged on the oncology market as adoptive cell transfers, specifically chimeric antigen receptor (CAR) T-cell therapies, with clear benefits in hematologic malignancy treatment.
Esther P. Black, PhD
Advertisement
Articles by Esther P. Black, PhD
Advertisement
Latest Updated Articles
Combating Advancing Cancers With CAR T-Cell TherapyPublished: September 8th 2019 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Semaglutide Shows Direct Organ-Protective Benefits Beyond Weight Loss in HFpEF
2
Immune Synergy May Explain Why Some Patients Achieve Durable Remission With Cilta-Cel
3
Neladalkib Shows Durable Responses in Heavily Pretreated ALK-Positive Lung Cancer
4
November 2025 Pharmacy Policy Updates
5
